| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5547948 | WYETH PHARMS | Controlled release of steroids from sugar coatings |
Jan, 2015
(9 years ago) | |
Premphase 14/14 is owned by Wyeth Pharms.
Premphase 14/14 contains Estrogens, Conjugated; Medroxyprogesterone Acetate.
Premphase 14/14 has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Premphase 14/14 are:
- US5547948
Premphase 14/14 was authorised for market use on 17 November, 1995.
Premphase 14/14 is available in tablet;oral-28 dosage forms.
The generics of Premphase 14/14 are possible to be released after 17 January, 2015.
Drugs and Companies using ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE ingredient
Market Authorisation Date: 17 November, 1995
Treatment: NA
Dosage: TABLET;ORAL-28
More Information on Dosage
PREMPHASE 14/14 family patents
